FDA Launches Pilot Program to Help Clinicians Choose LDTs to ID Cancer Biomarkers
The new FDA pilot program aims to improve safety related to the use of laboratory-developed tests to select appropriate cancer treatments for patients.
Read MorePosted by Melanie Hamilton-Basich | Jun 20, 2023 | Cancer |
The new FDA pilot program aims to improve safety related to the use of laboratory-developed tests to select appropriate cancer treatments for patients.
Read MorePosted by Chris Wolski | Jun 19, 2023 | Cancer |
A study shows that genomic sequencing panels, as they are currently used in clinical practice, are only useful in 5% of patients (one in 20).
Read MorePosted by Chris Wolski | Jun 16, 2023 | Diagnostic Technologies |
A novel technique has been devised to aid physicians in achieving more accurate diagnoses of limb girdle muscular dystrophy.
Read MorePosted by Chris Wolski | Jun 16, 2023 | Molecular Diagnostics |
Better education and access to laboratory tests are needed to improve early diagnosis and treatment of congenital CMV.
Read MorePosted by Melanie Hamilton-Basich | Jun 14, 2023 | Allergy & Autoimmune, Sequencing Systems |
The noninvasive method diagnoses atopic dermatitis by analyzing RNA from samples of sebum collected from infants using an oil-blotting film.
Read More